Antitumour Effects of SFX-01 Molecule in Combination with Ionizing Radiation in Preclinical and In Vivo Models of Rhabdomyosarcoma

RH30, RH4, RD, and JR1 cell lines as well as mouse xenograft models of rhabdomyosarcoma were used to evaluate the biological and molecular effects induced by SFX-01 treatment.